Gabay, Cem

Title Year Hits Downloads
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype 2017 39 15
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition 2017 9 1
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis 2017 10 0
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 10 0
The role of female hormonal factors in the development of rheumatoid arthritis 2017 33 0
Elevated serum levels of free interleukin-18 in adult-onset Still's disease 2016 19 0
Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice 2016 119 2
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells 2016 38 0
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis 2016 91 0
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 22 0
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration 2016 7 2
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines 2016 7 0
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study 2016 71 0
IL-1R1-MyD88 axis elicits papain-induced lung inflammation 2016 7 0
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype 2016 40 0
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease 2016 7 4
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease 2016 77 1
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis 2016 83 30
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling 2015 103 16
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice 2015 214 1
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study 2015 141 267
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry 2015 87 0
Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system 2015 230 3
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists 2015 70 0
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection 2015 73 44
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study 2015 93 0
Inflammation: IL-36 has proinflammatory effects in skin but not in joints 2014 169 0
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee 2014 146 0
Immune-mediated experimental arthritis in IL-33 deficient mice 2014 194 1
Biological agents in monotherapy for the treatment of rheumatoid arthritis 2014 172 2
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour 2014 200 2
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 2014 106 95
In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians 2014 186 1
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? 2014 95 0
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout 2014 200 0
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience 2013 248 99
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions 2013 138 124
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans 2013 168 59
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions 2013 185 124
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages 2013 170 1
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis" 2013 132 0
The severity of experimental arthritis is independent of IL-36 receptor signaling 2013 182 48
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply 2013 136 0
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial 2013 139 0
Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome 2013 152 0
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency 2013 209 58
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement 2013 172 75
Hand osteoarthritis: new insights 2013 186 0
Do synovial leptin levels correlate with pain in end stage arthritis? 2013 221 1
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial 2012 234 0
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments 2012 117 1
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration 2012 185 0
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? 2012 230 1
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis 2012 257 416
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis 2012 138 3
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells 2012 218 219
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis 2012 226 187
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease 2012 225 111
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists 2012 148 203
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients 2012 196 0
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters 2012 196 1
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice 2012 197 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study 2011 261 2
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions 2011 220 0
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection 2011 192 0
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center 2011 185 0
IL-33 biology with potential insights into human diseases 2011 186 0
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis 2011 195 0
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries 2011 119 0
IL-36R ligands are potent regulators of dendritic and T cells 2011 198 0
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study 2011 188 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients 2011 372 260
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients 2010 223 309
Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins 2010 134 322
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2010 173 0
Polyarthrite rhumatoïde,méthotrexate et fibrose pulmonaire : quelles évidences ? 2010 297 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 221 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 2010 186 0
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice 2010 124 0
The effect of alcohol on radiographic progression in rheumatoid arthritis 2010 192 0
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial 2010 201 0
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist 2010 188 0
IL-1 pathways in inflammation and human diseases 2010 240 0
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients 2010 194 0
Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists 2010 283 0
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis 2009 199 1
Mutations in the IL1RN locus lead to autoinflammation 2009 187 1
Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaounde-Cameroon 2009 169 0
Interleukin-33 is biologically active independently of caspase-1 cleavage 2009 129 233
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases 2009 176 0
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis 2009 182 0
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory 2009 176 2
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure 2009 116 0
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice 2009 323 583
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study 2009 147 7
Synovial tissues concentrate secreted APRIL 2009 196 201
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis 2009 181 0
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies 2009 234 151
Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? 2008 192 1
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc 2008 196 0
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 2008 191 0
At the horizon of innovative therapy in rheumatology: new biologic agents 2008 184 9
The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14 2008 188 0
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease 2008 192 0
IL-1, IL-18, and IL-33 families of cytokines 2008 296 963
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells 2007 136 0
Expression and function of junctional adhesion molecule-C in human and experimental arthritis 2007 202 154
Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein 2007 209 392
Leukocyte migration to rheumatoid joints: Enzymes take over 2006 164 1
Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis 2006 166 0
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes 2006 195 78
Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility 2005 121 148
Total hip prosthetic joint infection due to Veillonella species 2004 195 0
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice 2004 85 37
18272 6074